Proceedings of Extra-Ordinary General Meeting (EGM) of the Company held on 27th March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astonea Labs held an Extra-Ordinary General Meeting on 27th March 2026 in Panchkula, Haryana, with 8 members present in person. Eight resolutions were discussed and put to vote, including 7 Special Resolutions and 1 Ordinary Resolution. Key items included reallocation of unutilised IPO proceeds towards acquiring equity in M/s Damaira Pharmaceuticals Pvt. Ltd., ratification of the cost auditor's remuneration for FY 2025-26, adoption of a new set of Articles of Association, and approval of material related party transactions with three entities (Astonea One Pvt Ltd, Ascot Biolabs Pvt Ltd, and Shinto Organics) for FY 2026-27. Other resolutions covered approval for loans, guarantees and investments under Section 186, and remuneration of Executive Director Mr. Vikrant. E-voting was open from 23rd–26th March 2026, and the results will be announced within 48 hours.
Shareholders should watch for the voting results, especially on the reallocation of IPO funds for the Damaira Pharmaceuticals acquisition, which changes the stated use of IPO money. The approval of multiple related party transactions and executive director remuneration are governance items that minority shareholders may want to monitor closely.